These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17284635)

  • 1. Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects.
    Simsek S; Basoski NM; Bravenboer N; Zhang X; Mumm S; Whyte MP; Netelenbos JC
    J Clin Endocrinol Metab; 2007 May; 92(5):1897-901. PubMed ID: 17284635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of Paget's disease of bone.
    Daroszewska A; Ralston SH
    Clin Sci (Lond); 2005 Sep; 109(3):257-63. PubMed ID: 16104845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: genetics of Paget's disease of bone and related disorders.
    Daroszewska A; Ralston SH
    Nat Clin Pract Rheumatol; 2006 May; 2(5):270-7. PubMed ID: 16932700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.
    Whyte MP; Tau C; McAlister WH; Zhang X; Novack DV; Preliasco V; Santini-Araujo E; Mumm S
    Bone; 2014 Nov; 68():153-61. PubMed ID: 25063546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.
    Whyte MP
    Ann N Y Acad Sci; 2006 Apr; 1068():143-64. PubMed ID: 16831914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paget's disease: a clinical review.
    Shah M; Shahid F; Chakravarty K
    Br J Hosp Med (Lond); 2015 Jan; 76(1):25-30. PubMed ID: 25585180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK.
    Iwamoto SJ; Rothman MS; Duan S; Baker JC; Mumm S; Whyte MP
    Bone; 2020 Apr; 133():115224. PubMed ID: 31923705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders.
    Ralston SH
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):101-11. PubMed ID: 18328984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Inherited forms of Paget's Disease and Related Syndromes.
    Ralston SH; Taylor JP
    Calcif Tissue Int; 2019 May; 104(5):501-516. PubMed ID: 30756140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy.
    Craven M; Vajravelu ME; Shekdar KV; Levine MA; Mumm S; Whyte MP; Mancilla EE
    Bone; 2023 May; 170():116698. PubMed ID: 36740137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and aetiology of Pagetic disorders of bone.
    Helfrich MH; Hocking LJ
    Arch Biochem Biophys; 2008 May; 473(2):172-82. PubMed ID: 18359282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of Paget's disease of bone.
    Ralston SH
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).
    Whyte MP; Campeau PM; McAlister WH; Roodman GD; Kurihara N; Nenninger A; Duan S; Gottesman GS; Bijanki VN; Sedighi H; Veis DJ; Mumm S
    Bone; 2020 Aug; 137():115364. PubMed ID: 32298837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic disorders associated with the RANKL/OPG/RANK pathway.
    Xue JY; Ikegawa S; Guo L
    J Bone Miner Metab; 2021 Jan; 39(1):45-53. PubMed ID: 32940787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Paget's disease of bone with ocular manifestations and a novel TNFRSF11A duplication variant (72dup27).
    Saito-Hakoda A; Kikuchi A; Takahashi T; Yokoyama Y; Himori N; Adachi M; Ikeda R; Nomura Y; Takayama J; Kawashima J; Katsuoka F; Fujishima F; Yamaguchi T; Ito A; Hanita T; Kanno J; Aizawa T; Nakazawa T; Kawase T; Tamiya G; Yamamoto M; Fujiwara I; Kure S
    J Bone Miner Metab; 2023 Mar; 41(2):193-202. PubMed ID: 36520195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis.
    Whyte MP; Hughes AE
    J Bone Miner Res; 2002 Jan; 17(1):26-9. PubMed ID: 11771666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical response of TNFRSF11A-mediated early-onset familial Paget disease to bisphosphonate therapy.
    Riches PL; Imanishi Y; Nakatsuka K; Ralston SH
    Calcif Tissue Int; 2008 Oct; 83(4):272-5. PubMed ID: 18836673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology and genetics of metabolic bone disorders characterized by increased bone turnover.
    Beyens G; Van Hul W
    Crit Rev Eukaryot Gene Expr; 2007; 17(3):215-40. PubMed ID: 17725490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations.
    Bolland MJ; Tong PC; Naot D; Callon KE; Wattie DJ; Gamble GD; Cundy T
    J Bone Miner Res; 2007 Mar; 22(3):411-5. PubMed ID: 17181397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.